The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
It's not the MMs that do that.
https://www.proactiveinvestors.co.uk/companies/news/81/idiots-guide-to-the-london-stock-exchanges-setsmm-0379.html
RiverFort's website is rather embarrassing.
https://www.riverfort.com/post/_ukog
The future seems to hinge around BK's majority holding.
Any meaningful placing from him would change that.
He's young for a boss so little change of him retiring or stepping back for the foreseeable future.
I just wonder if there's a price he would consider being bought out for.
"Investors may despair at developments but can take some reassurance that the valuation is now much more robust"
It seems not.
https://www.lse.co.uk/rns/SONG/amendment-to-operative-net-asset-value-kbazogx05i4i2bf.html
This is the best guide I've seen to the reporting of trades.
https://www.proactiveinvestors.co.uk/companies/news/81/idiots-guide-to-the-london-stock-exchanges-setsmm-0379.html
I'm not sure about the accuracy of those reports, they're just an estimate based on midprice.
A lot of the big trades are at mid, so it depends how those are counted. Often has big late reported trades too.
This share always seems to have odd trading, I've never worked out if it's daytraded heavily or if big funds shift in an out (or both).
I'm tempted to topslice every time it gets above 1200p and look to buy back when it drops again, but haven't tried that yet.
"The Company has entered into a loan agreement with the Trustees to fund the subscription of the EBT Shares by the Trustees."
I'd like to know how that loan agreement will show in UKOG's accounts.